The majority of respondents experienced drug stock–out problems for their RHD patients, including penicillin (19/30), anticoagulants (17/30) and other cardiac drugs such as digoxin, ACE inhibitors, spironolactone and captopril (19/30) (Fig. 6). Here, ACE is linked to rheumatic heart disease.